CTRI/2023/08/057096RecruitingPhase 2
Radiolabeled fibroblast activation peptide inhibitors (FAPI) as a theranostic molecule in patients with carcinoma of epithelial origin - RNT (Radionuclide therapy)
Post Graduate Institute of Medical Education and Research, Chandigarh0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •. Patients older than 18 years of age
- •· Confirmed diagnosis: type of carcinoma
- •. Chemo refractory, multiple lesions or
- •unresectable single lesion
- •. Good uptake on diagnostic Ga-68 FAPI PET/CT
- •· Patients In good general condition (Karnofsky
- •performance status of more than 70)
- •· Ready to give written informed consent for the
- •protocol approved by IEC
Exclusion Criteria
- •· Pregnancy or lactation
- •· Poor kidney function
- •· Any other serious illness
- •· An overall survival expectancy of less than 1 month
Investigators
Similar Trials
Completed
Phase 1
Fibroblast growth factor receptors (FGFR) Inhibition for Epithelial Solid TumoursEpithelial Solid TumoursEpithelial tumourCancerISRCTN44149443niversity of Leeds (UK)28
Recruiting
Unknown
Pilot study of fibroblast activation factor expression in recurrent/progressive pancreatic cancer and mesothelioma using [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) -46 PET imaging.pancreatic cancerACTRN12623001078640Sir Charles Gairdner and Osborne Park Health Care Group30
Recruiting
Not Applicable
Gallium-68 fibroblast activation protein inhibitor (68Ga-FAPI) positron emission tomography/computed tomography (PET/CT) versus 18F-fluorodeoxyglucose (18F-FDG) PET/CT for pancreatic cancer: A feasibility studyPancreatic cancerCancer - PancreaticACTRN12622000695707I-MED Radiology Network10
Recruiting
Not Applicable
Co-stimulatory and -inhibitory molecules on tumor-infiltrating lymphocytes from cholangiocarcinomabile duct cancer10019815cholangiocarcinomaNL-OMON43309Stichting Leveronderzoek102
Recruiting
Not Applicable
rine Biomarkers in Cirrhotic Patients with Acute Kidney InjuryNovel biomarkerAcute kidney injuryCirrhosisTCTR20180905002Rachadapisek Sompot Fund107